Results 141 to 150 of about 2,026 (172)
Some of the next articles are maybe not open access.

Psychedelics move from agents of rebellion towards therapeutics

Nature Medicine, 2020
Once agents of the anti-establishment, psychedelics are now moving to the commercial market, with regulatory approvals and phase 3 trials opening the door to mainstream therapeutics.
openaire   +1 more source

Psychedelics and Supernatural Agents

Abstract The authors review the evidence for overlap in neurophysiologic, cognitive, and phenomenological features of REM sleep dreams and the psychedelic state. REM sleep and dreams contribute in complex ways to the phenomenology of both religious experiences and psychedelic experiences via intrusion of components of REM ...
Patrick McNamara, Jordan Grafman
openaire   +1 more source

Supernatural Agent Experiences on Psychedelics: A Predictive Account

Encounter with supernatural agents and other drug-occasioned immaterial entities are a common aspect of psychedelic experiences. However, existing theories offer incomplete explanations for this phenomenon. This paper proposes a theoretical model of psychedelic supernatural agent experiences grounded in active inference.
Zach Buck, John Vervaeke, Mark Miller
openaire   +1 more source

Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management

Current Pain and Headache Reports
Chronic pain affects approximately 1.5 billion people worldwide, representing the leading cause of disability and a significant financial burden on healthcare systems. Conventional treatments, such as opioids and non-steroidal anti-inflammatory drugs, are frequently linked to adverse effects, including dependency and gastrointestinal issues, and often ...
Natalie H, Strand   +10 more
openaire   +2 more sources

[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].

Der Nervenarzt
With the discovery of the antidepressive effects of ketamine and the increasing withdrawal of the pharmaceutical industry from the development of new psychotropic drugs, the psychiatric research into the clinical application of hallucinogens in psychiatry has literally blossomed in the last two decades.
Johannes, Jungwirth   +2 more
openaire   +1 more source

Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows

Drugs & Aging
The use of drugs with psychedelic and dissociative effects for the treatment of psychiatric illnesses has become increasingly popular in recent years. However, few trials have been conducted to determine the efficacy of these agents in the specific setting of treatment-resistant major depressive disorder (MDD) in older adults.
Lou Vinarcsik   +2 more
openaire   +2 more sources

Psychedelic agents for treatment-resistant depression

2022
Natalie Gukasyan, Roland R. Griffiths
openaire   +1 more source

Psychedelic-inspired drug discovery using an engineered biosensor

Cell, 2021
Lin Tian   +2 more
exaly  

Home - About - Disclaimer - Privacy